WEDNESDAYS AT SHEPPARD PRATT: "Involuntary Outpatient Commitment: the Data and the Controversy"

Baltimore, MD US
January 10, 2018

Mandating adherence to mental health treatment in the community is among the most contested human rights issues in mental health law. While most American jurisdictions have statutes nominally authorizing involuntary outpatient commitment—a legal order to adhere to prescribed treatment in the community—until recently few states made substantial use of these laws.

With the enactment of assisted outpatient treatment (AOT) in New York in 1999, in California in 2003, and in Florida, Michigan, and West Virginia in 2005, and the tragic deaths at Virginia Tech in the wake of a failed outpatient commitment order, policy interest in this topic has dramatically increased. In addition, Congress has stimulated interest in AOT by authorizing SAMHSA to offer AOT implementation grants to states. AOT can best be understood in the context of a broad movement to apply available "leverage" to induce people with serious mental disorder to become engaged in treatment.

This lecture will review the empirical literature on the effectiveness of the assisted outpatient treatment in the US, alongside the heated controversies about its use. We will also review research in New York to evaluate the effectiveness and cost impact of Kendra's Law, the largest and most intensively operationalized AOT program in the US.  

 

 

Target Audience

This activity is intended for physicians, nurses, psychologists, social workers, counselors and mental health professionals.

Learning Objectives

1.  Discuss the data on the effectiveness of involuntary outpatient commitment (OPC).


2.  Describe the controversy about the use of outpatient commitment.


3.  Recognize the American Psychiatric Association’s position statement on outpatient commitment.

Course summary
Available credit: 
  • 1.00 ACEP NBCC clock hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact hours for Nurses
  • 1.00 Category 1 credits for Social Workers
  • 1.00 CEU Hours for Psychologists
  • 1.00 Participation
Course opens: 
01/08/2018
Course expires: 
02/28/2018
Event starts: 
01/10/2018 - 12:00pm
Event ends: 
01/10/2018 - 1:00pm
Fee:
$0.00
Sheppard Pratt Health System
6501 North Charles Street
Conference Center
Baltimore, MD 21204
United States

Marvin S. Swartz, M.D., is Professor and Head of the Division of Social and Community Psychiatry, Director of Behavioral Health for the Duke University Health System and Director of the Duke AHEC Program. Dr. Swartz has been extensively involved in research and policy issues related to the organization and care of mentally ill individuals at the state and national level. He was a Network Member in the MacArthur Foundation Research Network on Mandated Community Treatment examining use of legal tools to promote adherence to mental health treatment and led the Duke team in conducting the first randomized trial of involuntary outpatient commitment in North Carolina and the legislatively mandated evaluation of Assisted Outpatient Treatment in New York. He co-led a North Carolina study examining the effectiveness of Psychiatric Advance Directives and the NIMH funded Clinical Antipsychotics Trials of Intervention Effectiveness study.  He is currently a co-investigator of a study of implementation of Psychiatric Advance Directives in usual care setting. He also serves as the Director of the National Resource Center on Psychiatric Advance Directives. Dr. Swartz was the recipient of the 2011 American Public Health Association’s Carl Taube Award, the 2012 American Psychiatric Association’s Senior Scholar, Health Services Research Award for career contributions to mental health services research and the 2015 Isaac Ray Award from the American Psychiatric Association for career contributions to forensic psychiatry.

Marvin S. Swartz, M.D., is Professor and Head of the Division of Social and Community Psychiatry, Director of Behavioral Health for the Duke University Health System and Director of the Duke AHEC Program. Dr. Swartz has been extensively involved in research and policy issues related to the organization and care of mentally ill individuals at the state and national level. He was a Network Member in the MacArthur Foundation Research Network on Mandated Community Treatment examining use of legal tools to promote adherence to mental health treatment and led the Duke team in conducting the first randomized trial of involuntary outpatient commitment in North Carolina and the legislatively mandated evaluation of Assisted Outpatient Treatment in New York. He co-led a North Carolina study examining the effectiveness of Psychiatric Advance Directives and the NIMH funded Clinical Antipsychotics Trials of Intervention Effectiveness study.  He is currently a co-investigator of a study of implementation of Psychiatric Advance Directives in usual care setting. He also serves as the Director of the National Resource Center on Psychiatric Advance Directives. Dr. Swartz was the recipient of the 2011 American Public Health Association’s Carl Taube Award, the 2012 American Psychiatric Association’s Senior Scholar, Health Services Research Award for career contributions to mental health services research and the 2015 Isaac Ray Award from the American Psychiatric Association for career contributions to forensic psychiatry.

Disclosure Information

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers and speakers have been asked to disclose any relationship he /she or their spouse/partner has with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt Health System, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.
 
Marvin S. Swartz, M.D. reports having no financial interest, arrangement or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months. He will not discuss any medications, off-label uses or other medical products or services in this presentation.

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months: Ellen Mongan, M.D., Caroline Cahn, LCSW-C, Tom Flis, LCPC, Faith Dickerson, Ph.D., Robert Roca, M.D., Drew Pate, M.D., Meena Vimalananda, M.D., Briana Riemer, M.D. Ernestine Crosby, APRN, Darby Subotich, RN, MSN, Rick Wallace, RN, MSN, Jacqueline Williams-Porter, RN, MBA, Jennifer Tornabene, and Bonnie Katz.

Physician Statement: Sheppard Pratt Health System is accredited by The Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity.  Sheppard Pratt Health System designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Statement: Sheppard Pratt Health System is an approved provider of continuing nursing education by Maryland Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity. This activity is approved for 1.0 contact hours for nurses.

Psychologist Statement: Sheppard Pratt Health System is authorized by the State Board of Examiners of Psychologists as a sponsor of continuing education. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity.  Sheppard Pratt Health System designates this educational activity for a maximum of 1.0 CEU hours for Psychologists. Psychologists should claim credit commensurate with the extent of their participation in the activity.

Social Worker Statement: Sheppard Pratt Health System is authorized by the Board of Social Work Examiners of Maryland to offer continuing education for Social Workers.  Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity. This activity is approved for 1.0 CEU contact hours in Category 1 credits for Social Workers.

Counselor Statement:  Sheppard Pratt Health System has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 5098.  Programs that do not qualify for NBCC credit are clearly identified.  Sheppard Pratt Health System is solely responsible for all aspects of the program.  This activity is available for 1.0 NBCC clock hours.

Available Credit

  • 1.00 ACEP NBCC clock hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact hours for Nurses
  • 1.00 Category 1 credits for Social Workers
  • 1.00 CEU Hours for Psychologists
  • 1.00 Participation

Price

Fee:
$0.00
Please login or register to take this course.